| SKU | Size | Availability | Price | Qty |
|---|---|---|---|---|
| C130175-25mg | 25mg | 3 | $69.90 | |
| C130175-100mg | 100mg | 3 | $232.90 | |
| C130175-500mg | 500mg | 4 | $1,047.90 | |
| C130175-1g | 1g | 1 | $1,885.90 |
| Synonyms | Sodium Cholesteryl Sulphate | CS-0028847 | Cholesteryl sulfate (sodium) | DTXSID00951301 | AKOS015917524 | Cholesterol 3-sulfate sodium salt | AS-71701 | HY-111355B | [(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11, |
|---|---|
| Specifications & Purity | ≥98% |
| Storage Temp | Store at -20°C |
| Shipped In | Ice chest + Ice pads |
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Pubchem Sid | 504769633 |
|---|---|
| Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/504769633 |
| IUPAC Name | sodium;[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] sulfate |
| INCHI | InChI=1S/C27H46O4S.Na/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(31-32(28,29)30)13-15-26(20,4)25(22)14-16-27(23,24)5;/h9,18-19,21-25H,6-8,10-17H2,1-5H3,(H,28,29,30);/q;+1/p-1/t19-,21+,22+,23-,24+,25+,26+,27-;/m1./s1 |
| InChi Key | LMPVQXVJTZWENW-KPNWGBFJSA-M |
| Canonical SMILES | CC(C)CCCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OS(=O)(=O)[O-])C)C.[Na+] |
| Isomeric SMILES | C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OS(=O)(=O)[O-])C)C.[Na+] |
| WGK Germany | 3 |
| PubChem CID | 23679068 |
| Molecular Weight | 488.70 |
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
 D2502216 | Certificate of Analysis | Mar 17, 2025 | C130175 |
| D2502217 | Certificate of Analysis | Mar 17, 2025 | C130175 |
| D2502218 | Certificate of Analysis | Mar 17, 2025 | C130175 |
| D2516671 | Certificate of Analysis | Mar 17, 2025 | C130175 |
| F2301272 | Certificate of Analysis | Mar 04, 2025 | C130175 |
| F2301275 | Certificate of Analysis | Mar 04, 2025 | C130175 |
| F2301332 | Certificate of Analysis | Mar 04, 2025 | C130175 |
| F2301333 | Certificate of Analysis | Mar 04, 2025 | C130175 |
| F2301339 | Certificate of Analysis | Mar 04, 2025 | C130175 |
| H2231234 | Certificate of Analysis | Jun 13, 2024 | C130175 |
| H2231242 | Certificate of Analysis | Jun 13, 2024 | C130175 |
| F2301337 | Certificate of Analysis | May 20, 2023 | C130175 |
| K2404568 | Certificate of Analysis | May 20, 2023 | C130175 |
| K2404571 | Certificate of Analysis | May 20, 2023 | C130175 |
| H2231233 | Certificate of Analysis | Aug 12, 2022 | C130175 |
| H2231235 | Certificate of Analysis | Aug 12, 2022 | C130175 |
| WGK Germany | 3 |
|---|
| 1. Xiaogang An, Renfeng Wang, Erfang Chen, Yang Yang, Bei Fan, Yao Li, Bang Han, Qiong Li, Zhenzhen Liu, Yu Han, Jun Chen, Dingjun Zha. (2022) A forskolin-loaded nanodelivery system prevents noise-induced hearing loss. JOURNAL OF CONTROLLED RELEASE, 348 (148). [PMID:35659555] [10.1016/j.jconrel.2022.05.052] |
| 1. Xiaogang An, Renfeng Wang, Erfang Chen, Yang Yang, Bei Fan, Yao Li, Bang Han, Qiong Li, Zhenzhen Liu, Yu Han, Jun Chen, Dingjun Zha. (2022) A forskolin-loaded nanodelivery system prevents noise-induced hearing loss. JOURNAL OF CONTROLLED RELEASE, 348 (148). [PMID:35659555] [10.1016/j.jconrel.2022.05.052] |
